Lazarillo-related Lipocalins confer long-term protection against type I Spinocerebellar Ataxia degeneration contributing to optimize selective autophagy
© del Caño-Espinel et al.; licensee BioMed Central. 2015
Received: 24 May 2014
Accepted: 2 March 2015
Published: 19 March 2015
A diverse set of neurodegenerative disorders are caused by abnormal extensions of polyglutamine (poly-Q) stretches in various, functionally unrelated proteins. A common feature of these diseases is altered proteostasis. Autophagy induction is part of the endogenous response to poly-Q protein expression. However, if autophagy is not resolved properly, clearance of toxic proteins or aggregates cannot occur effectively. Likewise, excessive autophagy induction can cause autophagic stress and neurodegeneration. The Lipocalins ApoD, Glial Lazarillo (GLaz) and Neural Lazarillo (NLaz) are neuroprotectors upon oxidative stress or aging. In this work we test whether these Lipocalins also protect against poly-Q-triggered deterioration of protein quality control systems.
Using a Drosophila retinal degeneration model of Type-1 Spinocerebellar Ataxia (SCA1) combined with genetic manipulation of NLaz and GLaz expression, we demonstrate that both Lipocalins protect against SCA1 neurodegeneration. They are part of the endogenous transcriptional response to SCA1, and their effect is non-additive, suggesting participation in a similar mechanism. GLaz beneficial effects persist throughout aging, and appears when expressed by degenerating neurons or by retinal support and glial cells. GLaz gain-of-function reduces cell death and the extent of ubiquitinated proteins accumulation, and decreases the expression of Atg8a/LC3, p62 mRNA and protein levels, and GstS1 induction. Over-expression of GLaz is able to reduce p62 and ubiquitinated proteins levels when rapamycin-dependent and SCA1-dependent inductions of autophagy are combined. In the absence of neurodegeneration, GLaz loss-of-function increases Atg8a/LC3 mRNA and p62 protein levels without altering p62 mRNA levels. Knocking-down autophagy, by interfering with Atg8a or p62 expression or by expressing dominant-negative Atg1/ULK1 or Atg4a transgenes, rescues SCA1-dependent neurodegeneration in a similar extent to the protective effect of GLaz. Further GLaz-dependent improvement is concealed.
This work shows for the first time that a Lipocalin rescues neurons from pathogenic SCA1 degeneration by optimizing clearance of aggregation-prone proteins. GLaz modulates key autophagy genes and lipid-peroxide clearance responsive genes. Down-regulation of selective autophagy causes similar and non-additive rescuing effects. These data suggest that SCA1 neurodegeneration concurs with autophagic stress, and places Lazarillo-related Lipocalins as valuable players in the endogenous protection against the two major contributors to aging and neurodegeneration: ROS-dependent damage and proteostasis deterioration.
KeywordsAutophagy Neurodegeneration Neuroprotection Polyubiquitinated protein clearance Drosophila GLaz NLaz ApoD GstS1 Atg1/ULK1 Atg4a Atg8a/LC3 p62
A diverse set of neurodegenerative disorders are caused by abnormal extensions of polyglutamine (poly-Q) stretches in various, functionally unrelated proteins. No effective treatment to prevent or slow down the progression of poly-Q-based neurodegeneration is currently available. Since anomalous glutamine extensions lead to protein misfolding and aggregation, independently of the particular protein affected, all of these diseases display altered cellular proteostasis  as a common feature. The mechanisms engaged in protein quality control, mainly the ubiquitin-proteasome and autophagy systems, are obvious candidate processes on which to focus therapeutic manipulations, aiming at the clearance of mutant proteins. Because poly-Q proteins tend to oligomerize, autophagy is thought to play a prominent role in their management. However, autophagic responses to pathological damage are not yet well understood. Very diverse modes of experimental or pharmacological induction of autophagy have proven to be protective in poly-Q disease models (reviewed in ). Also, induction of autophagy has been proposed to be part of the natural response of cells upon glutamine-extended protein expression . However, increased levels of autophagy do not always have beneficial effects on poly-Q-based neurodegeneration. Nisoli et al.  showed that induction of autophagy does not rescue the neurodegeneration caused by poly-Q-extended atrophin-1 in a fly model of DRPLA (dentatorubral-pallidoluysian atrophy). If autophagy is induced but not resolved properly, clearance of damaged and unfolded proteins cannot take place effectively. Also, excessive or imbalanced induction of autophagy might be deleterious if autophagosome turnover is unable to keep pace with its formation . This situation will produce autophagic stress, which can actively contribute to neuronal atrophy, neurite degeneration and cell death [6,7].
We have studied the functions of an evolutionarily-related group of proteins belonging to the Lipocalin family, named Lazarillo in invertebrates (Laz, GLaz and NLaz) and Apolipoprotein D (ApoD) in vertebrates. They are secreted proteins with a single globular ß-barrel domain that forms a “cup-like” structure with ability to bind small molecules, mostly hydrophobic in nature . Hydrophobic ligands as varied as retinoic acid, arachidonic acid, progesterone, sphingomyelin, the pheromone 7(d)tricosene, or the endocannabinoid anandamide, have been shown to bind to some of these Lazarillo-related Lipocalins [9-11].
Lazarillo-related Lipocalins show neuroprotective effects in mice and lifespan extending abilities in flies, both under normal conditions and upon exposure to oxidative stress or injury [12-21]. These neuroprotective functions are mediated either by counteracting lipid peroxidation or by controlling myelin phagocytosis in injured nerves [20,22]. Moreover, ApoD stands among a small set of genes whose over-expression upon nervous system aging is conserved in mammals [23,24], and its over-expression is extensively correlated with a wide spectrum of nervous system damage, like stroke or meningoencephalitis, psychiatric disorders like schizophrenia or bipolar disorder, and neurodegenerative diseases like Alzheimer, Parkinson, Huntington, Niemann Pick or multiple sclerosis (reviewed in [25-27]).
Physiological aging and age-related pathologies share many causal factors (reviewed in ), and it is not surprising that protective agents are also shared, even though the particular form or the rate of damage accumulation might vary. Two of the major factors contributing to aging and neurodegeneration are (1) reactive oxygen species (ROS)-mediated damage and (2) deterioration of protein and organelle quality control systems.
We have previously tested the protective effect of a Lazarillo-related Lipocalin, GLaz, on the degeneration caused by a primarily mitochondrial dysfunction disease, Friedreich ataxia, a neurodegenerative disorder with a redox imbalance as a major contributor to its pathophysiology. GLaz is able to counteract some of the effects of frataxin deficiency, reducing the level of lipid peroxidation and free fatty acids, and leading to improved survival of frataxin-deficient flies . Yet, given the variety of neurodegenerative conditions that concur with ApoD over-expression, these Lipocalins are probably important elements of the shared set of protective agents. Thus, it is pertinent to ask whether Lipocalins can protect from neurodegenerative disorders with very different etiology, such as the poly-Q based pathologies.
We therefore set to study the effects of the Drosophila Lipocalins GLaz and NLaz on a poly-Q triggered ataxia model, the Type I Spinocerebellar Ataxia (SCA1) , to focus on their effect on protein and organelle quality control systems, the other major factor whose deterioration is causative to aging. Until now, no Lipocalin has been tested for its ability to modify poly-Q-based neurodegeneration and this work represents a first test for extracellular lipid-binding proteins as modulators of proteostasis under neurodegenerative conditions.
The Lipocalin GLaz is up-regulated upon neurodegeneration by pathogenic human Ataxin 1, and it is expressed locally in the fly retina
The expression of human ApoD is boosted upon various neurodegenerative conditions (for reviews see [25-27]), but SCA1 is still unexplored. We therefore tested whether the Drosophila Lipocalins change their expression in SCA1-affected flies.
Since these results demonstrate that GLaz, like ApoD in vertebrates, is part of the natural response of the tissue to the neurodegenerative insult, we characterized its expression in the Drosophila eye, searching for cells that might influence the tissue response to the neurodegenerative condition. To assay for GLaz expression we used two independent insertions of a fusion protein construct (glaz:GLaz-GFP[FX] and glaz:GLaz-GFP[F2] ). These reporters show GFP-positive cells in the retina (Figure 1B). The GLaz signal does not co-localize with the neuronal marker 22C10 (Figure 1Bb), suggesting that support retinal cells (arrows in Figure 1B) and retinal basal glia (arrowhead in Figure 1B) are the source of this Lipocalin.
Co-expression of GLaz with extended poly-Q human Ataxin 1 ameliorates photoreceptor degeneration
To test whether GLaz is able to protect cells that are degenerating due to the expression of hATXN182Q, we either expressed the Lipocalin in the degenerating photoreceptors (using the same controller to drive the expression of the poly-Q protein and GLaz), or in the cells naturally expressing the GLaz protein under the control of its native promoter (using a glaz:GLaz-GFP construct).
We first demonstrated that the expression of the UAS:GLaz transgene does not directly cause an alteration in the amount of hATXN182Q produced in photoreceptors by quantifying the hATXN182Q immunolabeling signal in eye imaginal discs of 3rd instar larva (Additional file 1). This time point was chosen to avoid variation in the number of of hATXN182Q-expressing cells, since cell death caused by neurodegeneration is not present yet .
Human Ataxin 1 was detected by immunohistochemistry in the retina sections (Figure 1F). Nuclear inclusion bodies of the extended poly-Q protein are evident in the photoreceptors expressing hATXN182Q as previously described . The expression of GLaz does not fully abolish the formation of these protein aggregates (arrows in Figure 1F) in spite of the preserved tissue integrity.
Taken together our data show that GLaz ameliorates the hATXN182Q-provoked degeneration, but there seems to be a limited range of the disease severity where GLaz can exert a beneficial effect when expressed by the degenerating photoreceptors.
GLaz rescues degeneration of photoreceptor neurons in a stable manner when produced by its native cell expression domain
Since the Lazarillo-related fly Lipocalins are secreted proteins [9,32], we further tested if GLaz expressed with its native spatiotemporal pattern would be able to protect photoreceptors when accessing the degenerating cell from the extracellular space. We tested the effect of GLaz gain-of-function by expressing, in wild type background, the GLaz-GFP fusion protein under the control of the native GLaz promoter (glaz:GLaz-GFP [F2] or glaz:GLaz-GFP[FX] insertion lines) on the pathogenic human poly-Q Ataxin 1-generated photoreceptor degeneration (Figure 2A,B and Additional file 4). The rescue is present from early stages of degeneration in the pupal eyes, 5 days after pupa formation (APF), to aged adult flies (30 days old) (Additional file 4). These results show that the rescue does not require Lipocalin expression in the degenerating cell, and that the GLaz protecting effect can be exerted when the source of protein is a different cell. The support and basal glial cells in the retina are the closest natural source of GLaz in this case (Figure 1B). Therefore GLaz can act as an extrinsic factor protecting the photoreceptors in a non-cell-autonomous manner. This paracrine neuroprotective mechanism is stable enough to maintain retinal rescue in aged flies (30 days old flies, Figure 2A and Additional file 4).
GLaz-GFP protein localization is evident in cells undergoing degeneration in 5–6 days old flies (Figure 2Ca,b). When analyzing mildly degenerated regions of retinas at 4d-APF, no GLaz-GFP signal is detected in the hATXN182Q-expressing photoreceptors (Figure 2Cc). However, more degenerated regions of retina showed GLaz protein signal co-localizing with the photoreceptor marker 4C5 (Figure 2Cd). These results suggest a potential incorporation of the extracellular protein into the degenerating photoreceptors that resembles the internalization of exogenous ApoD observed in cultured astrocytes .
The Lipocalin NLaz is up-regulated by pathogenic poly-Q Ataxin 1 expressed in the fly retina, and rescues photoreceptor neurodegeneration
Nevertheless, co-expressing NLaz with hATXN182Q in retinal photoreceptors under the control of the gmr:GAL4 driver protects cells from degeneration (Figure 3B and Additional file 2B). The rescue level obtained with NLaz was similar to that with GLaz, as quantified by the degree of surface regularity (Figures 2B and 3D, 66-84% rescue with GLaz, 80% rescue with NLaz). Interestingly, the rescue attained by each Lipocalin is comparable to that obtained when both GLaz and NLaz are over-expressed in photoreceptors (Figure 3C,D, 80% rescue), suggesting that both proteins could be acting through the same mechanism and no additive effect is obtained.
Since GLaz is natively expressed in cells within the niche of the degenerating photoreceptors in the SCA1 model, we focused on this Lipocalin for the subsequent search of the cellular mechanism causative of neuroprotection.
Over-expressing GLaz decreases apoptotic cell death in the presence of expanded human Ataxin 1
GLaz alters the expression of a SCA1 phenotype-modifier controlling lipid peroxide clearance
Among the genes found to modify SCA1-induced neurodegeneration in Drosophila, two genes involved in lipid management were uncovered [30,33]: Glutathione S transferase S1 (GstS1), a homologue of the mammalian hematopoietic prostaglandin D synthase (HPGDS), and Vibrator (Vib) a phosphatidylinositol transfer protein, homologue of PITPN-alpha in vertebrates. Over-expression of GstS1 or Vib suppresses the neurodegeneration caused by the poly-Q human Ataxin 1, and the loss of function of GstS1 enhances the phenotype [30,33].
Although GstS1 is classified as part of the constitutively expressed oxidative stress defensive enzymes , no transcriptional regulation upon neurodegeneration has been described for GstS1 or Vib. We explored the putative transcriptional regulation of these two genes in our system. While no modification of Vib transcript levels was seen in the SCA1 model either alone or combined with over-expression of GLaz, a 4-fold induction of the GstS1 transcript was obtained upon hATXN182Q-induced photoreceptor degeneration (Figure 4C). This induction was significantly reduced when GLaz is over-expressed (Figure 4C).
The direct cause of GstS1 up-regulation under SCA1-induced neurodegeneration remains to be explored. However, since GLaz controls lipid peroxide levels , we propose a mechanistic link between the lower levels of oxidized substrates upon GLaz gain-of-function and the decreased GstS1 transcription. Thus, the ectopic expression of poly-Q hAtaxin 1 results in the induction of both GLaz and GstS1 genes, and they contribute to an efficient lipid peroxide clearance. Other lipid management genes, like Vib, are not induced even though Vib is also a modifier of SCA1 neurodegenerative phenotype.
SCA1-dependent build-up of ubiquitinated proteins is reduced by GLaz over-expression
Over-expression of GLaz reduces SCA1-dependent Atg8a induction
A defense mechanism against lipid peroxides in a ROS-promoting environment, and a mechanism controlling proteostasis seem unconnected processes at first glance. However, links between these mechanisms are starting to emerge. GstS1 is oxidized while catalyzing the conjugation of lipophilic substrates with reduced glutathione, and this fact has another consequence: the induction of autophagy by the Jun-N-terminal Kinase (JNK) when this kinase is released from the inhibitory interaction of the reduced form of GstS1 protein . On the other hand, ubiquitinated proteins are known to be degraded by autophagy in neurons [35-37]. Thus, we hypothesized that the protective effects of proteins like Lipocalins, influencing both lipid oxidation and proteostasis, might be related to the membrane-mediated process of autophagy, potentially adding another link between these processes.
When GLaz is over-expressed in the photoreceptors or in retinal support cells and basal glial cells, the SCA1-dependent Atg8a induction is significantly reduced (Figure 6B). Thus, a paradox arises from the data presented so far (Figures 5 and 6), since GLaz gain-of-function reduces accumulation of ubiquitinated proteins, but at the same time reduces the levels of an indicator of autophagic activity induction (Atg8a) and an oxidative stress defensive enzyme that affects autophagic activity (GstS1). When autophagy is further stimulated by feeding SCA1 model flies with rapamycin (a TOR signalling inhibitor; see  for a review), two important consequences are observed: 1) more autophagic induction results in higher levels of ubiquitinated proteins, instead of enhanced clearance, and 2) GLaz over-expression reduces the accumulation of ubiquitinated proteins (Figure 6C). The first observation suggests that autophagy promotion alone is not beneficial in the SCA1 neurodegeneration model, leading instead to autophagic stress [6,7] that ultimately makes ubiquitinated proteins clearance less efficient. Although rapamycin treatment, in addition to autophagy induction, might have wider effects on protein homeostasis, it is clear that the combination of rapamycin treatment with GLaz over-expression results in an enhanced clearance of ubiquitinated proteins (Figure 6C).
These data could support different scenarios: (i) The GLaz antioxidant properties contribute to maintain induction of autophagy and other antioxidant systems at an appropriate level where these mechanisms are most effective. (ii) GLaz is not directly acting on the induction or initiation steps of autophagy, but rather promoting its resolution, making the process to progress more efficiently. (iii) The GLaz contribution to the protein quality control systems is independent of autophagy (e.g., by potentiating proteasomal function).
GLaz prevents p62 accumulation upon SCA1-dependent and rapamycin-stimulated autophagy
However, we need to discern whether p62 protein level changes are accompanied by transcriptional changes upon GLaz over-expression. We then measured the p62 transcript levels by qRT-PCR (Figure 7D) and found no significant changes upon hATXN182Q or GLaz over-expression alone, while a 25% decrease is observed by over-expressing GLaz in the SCA1 model compared to the neurodegenerative condition. These results show that GLaz over-expression results in both p62 mRNA and protein levels decrease in the SCA1 model.
In the absence of neurodegeneration, a loss of GLaz function increases Atg8a mRNA and p62 protein levels
Knocking-down key autophagy genes rescues SCA1-triggered neurodegeneration, and further GLaz-dependent rescue is abolished
All forms of autophagy reduction tested produce a significant rescue of photoreceptor degeneration (Figure 9), suggesting that in this neurodegenerative condition, autophagy must be contributing to neuronal death. These data, together with the observed accumulation of ubiquitinated proteins upon autophagy induction in the SCA1 model flies, suggest that hATXN182Q expressing cells are suffering autophagic stress [6,7]. GLaz over-expression under all four conditions of autophagy down-regulation results in a rescue of the rough eye phenotype, that is either similar or even slightly better than when autophagy is not genetically modified. No significant additive effect of both rescuing manipulations is observed, thus reflecting epistatic relationship between GLaz and autophagy control genes.
We have used the Drosophila retina as a cellular substrate to model the poly-Q-based SCA1 neurodegenerative disease, and found that two lipid-binding proteins, the Drosophila Lipocalins GLaz and NLaz, are able to counteract cellular damage and maintain cell viability and tissue integrity to a reasonable extent. Both Lipocalin genes are part of the endogenous transcriptional response to the neurodegenerative insult triggered by the expanded poly-Q human Ataxin 1. The beneficial effects of GLaz occur when the Lipocalin is either expressed by the degenerating neuron, or in a paracrine manner by the nearby support cells or basal glial cells. Neurodegeneration rescue is abolished by a GLaz interfering RNA construct, further supporting the effect specificity. Moreover, the neuroprotective effect of GLaz is persistent as the animal ages.
The fact that nuclear inclusions of poly-Q-Ataxin 1 are still present in GLaz over-expressing flies, suggests a role for GLaz in processes occurring in the cytoplasm of the affected cells. We have detected co-localization of the GLaz-GFP fusion protein with photoreceptor markers in the neurodegenerative SCA1 model. Likewise, human ApoD is internalized by murine astrocytes, and the internalized exogenous Lipocalin is observed in intracellular membranous and vesicular compartments, but not inside the nucleus . A similar intracellular traffic of GLaz is expected, and therefore worth to study. Interestingly, we have also recently found that ApoD, in addition to perform extracellular functions in injured peripheral nerves (controlling lipid mediators), promotes myelin degradation by macrophages , an intracellular process that also involves the formation of phagosomes.
Induction of autophagy has been shown in a Huntington disease model in response to the pathogenic mutant version of huntingtin , and induction of mRNA and protein p62 expression have been demonstrated upon expression of poly-Q expanded huntingtin . On the other hand, experimental induction of autophagy is beneficial in most, but not all, proteinopathies tested so far . Until now, the role of autophagy in SCA1 pathogenesis was unclear. Here we show that autophagy is also part of the tissue response to the expression of the human pathogenic version of Ataxin 1. We demonstrate that inhibition of the autophagy process in vivo rescues the fly retina from SCA1-triggered damage and that induction of autophagy in SCA1 flies compromises ubiquitinated proteins clearance. These results agree with the conclusions reached by recent works showing that activation of autophagy in neurons under autophagic stress compromises neuronal survival . Similarly, autophagy induction, autophagosome accumulation and increased levels of ubiquitinated proteins are accompanied by decreased mTOR signaling . Therefore, our data support that cells might be undergoing autophagic stress in this model [6,7], and that this cellular response is probably lowering the threshold for the onset of apoptotic cell death . This information is relevant in the context of the use of this Drosophila retinal degeneration model of SCA1 to search for genetic modifiers [30,33].
Our data support the view that GLaz beneficial effect on SCA1 neurodegeneration concurs with the modulation of neurodegeneration-triggered selective autophagy. GLaz shows epistatic relationships with autophagy genes involved in the induction of phagofore formation; Atg8a/ LC3 processing (conditioning the expansion into autophagosomes); targeting aggregated proteins cargo into the phagofore; and replenishing Atg8 and p62 levels upon autophagic activity. Moreover, in the SCA1 model, over-expressing GLaz lowers endogenous Atg8a and p62 transcript levels, as well as p62 protein levels, suggesting a decrease in autophagic activity that might counteract excessive autophagy induction. The loss of GLaz function increases Atg8a mRNA levels and leads to p62 protein accumulation in basal conditions, also suggesting a role in the modulation of basal autophagic activity. Although the observed decrease in p62 protein upon GLaz over-expression in SCA1 model flies, or the p62 protein accumulation in GLaz null mutants in basal conditions, could also be interpreted as signs of autophagy flux alterations , the small but parallel changes in p62 transcription under neurodegenerative conditions cast doubts on this scenario as the sole explanation.
We have previously shown that GLaz and NLaz have beneficial effects under oxidative stress elicited either experimentally, through normal aging [12-16], or evoked by Friedreich Ataxia, a mitochondrial dysfunction-based neurodegenerative disease . The control of lipid peroxidation levels lies at the base of these outcomes. Here we find that the Lipocalin GLaz is also able to rescue photoreceptors from pathogenic SCA1-induced apoptotic cell death by an apparently different mechanism. Interestingly, several control points of autophagy are either directly regulated by the cell redox state or are part of feedback regulatory loops in which oxidative stress or lipid peroxide levels are involved: (i) The activity of the cysteine protease Atg4a is redox sensitive [51,52]. (ii) The expression of p62 is induced by oxidative stress  and, in turn, p62 works as a signaling molecule promoting antioxidant response through its effect on Nrf2 transcription factor activation . (iii) GstS1 activity modulates autophagy though its regulation of the JNK pathway . Interestingly, GLaz null mutants display increased oxidative stress sensitivity, higher levels of lipid peroxidation and apoptotic cell death ; phenotypes that are often associated with autophagy malfunction. Thus, a parsimonious hypothesis would be that the Lipocalin-mediated control of lipid peroxide levels influences autophagy at several steps, slowing down the process and ultimately making it more efficient. These functions will promote clearance of aggregated proteins and would prevent crossing the threshold to apoptotic cell death programs. We thus propose that GLaz participates in the optimization of autophagy, contributing to make this process efficient and preventing autophagic stress, which would, in due time, develop alongside the severe degeneration produced by a relentless hATXN182Q expression under the UAS-GAL4 system.
It is known that autophagy defects lead to neurodegeneration even in cases where poly-Q protein expansions are not involved; e.g., in the Pink1 and Parkin loss-of-function leading to Parkinson disease, where mitophagy defects are proposed to induce neuronal death [55,56]. Therefore, the Lazarillo-related Lipocalins, with their potential to modulate autophagy, might be useful in many other neurodegenerative diseases. Also, it is known that autophagy efficacy decreases with aging . How is autophagy activity modulation contributing to the well-known longevity modulation phenotypes of GLaz and other Lazarillo-related Lipocalins [12-16] becomes an interesting future research avenue. Another member of the Lipocalin family, Lcn2, has been involved in autophagy modulation in murine embryonic cells, where loss of Lcn2 function results in a decrease in LC3 protein expression .
In summary, the Lazarillo-related Lipocalins, known to protect membranes from lipid peroxidation and its collateral damages, are also contributing to prevent autophagic stress under poly-Q-based neurodegenerative conditions. Understanding this pleiotropic nature of ApoD and Lazarillo-related Lipocalins will help us to better explain why ApoD is a key element in the nervous system response to such a wide array of neurodegenerative and injury-triggered diseases.
Two extracellular lipid binding proteins, GLaz and NLaz, are able to counteract cellular damage and maintain tissue integrity when the retina is suffering from the deleterious effects of expressing a poly-Q-expanded version of human Ataxin 1.
Both Lipocalins are part of the endogenous transcriptional response to the neurodegenerative insult, as ApoD is in many other nervous system diseases. GstS1, which contributes to lipid-peroxide clearance, is also induced in the SCA1 model.
The beneficial effects of GLaz can be exerted both, from within the degenerating neuron, or in a paracrine manner from the nearby support and basal glial cells.
The neuroprotective effect of GLaz is persistent with age.
GLaz gain-of-function reduces the amount of ubiquitinated proteins in neurodegenerative conditions.
GLaz loss-of-function increases Atg8a mRNA, and leads to p62 protein accumulation without a concomitant increase in its mRNA levels.
GLaz gain-of-function decreases SCA1-dependent induction of Atg8a and p62 mRNA and decreases p62 protein levels in the degenerated tissue.
Genetic down-regulation of autophagy rescues SCA1-triggered neurodegeneration, and pharmacological up-regulation of autophagy does not promote ubiquitinated proteins clearance in the SCA1 model, suggesting that cells are undergoing autophagic stress.
Epistasis genetic analysis with down-regulators of the autophagy process demonstrates that GLaz beneficial effects concur with a restrain in the extent of selective autophagy activity, which ultimately leads to an improved clearance of aggregation-prone proteins.
GLaz is able to improve ubiquitinated protein clearance even when combining SCA1-dependent with pharmacological inductions of autophagy. This result opens the possibility of an effective combination of therapeutic interventions, not only for SCA1, but for many other neurodegenerative diseases.
Lazarillo-related Lipocalins, including ApoD, can now be understood as useful and efficient players in the endogenous protection against the two major factors contributing to aging and neurodegeneration: ROS-dependent damage and proteostasis deterioration.
Fly strains and husbandry
Flies were grown under standard laboratory conditions as described . Fly females were used in all experiments. Unless stated otherwise, experiments were performed at 25°C.
The null mutant GLazΔ2/Δ2 and its isogenic wild type control (WTG10) in Canton S background were previously described . We used a construct (glaz:GLaz-GFP) containing 1.9 kb of the native 5’ genomic region upstream and the full-length GLaz gene, in frame with the coding sequence of GFP, thus producing a GLaz-GFP fusion protein expressed under the control of the native GLaz regulatory sequences . Two independent transformant lines with insertions of this construct were used: 1) glaz:GLaz-GFP[FX] and 2) glaz:GLaz-GFP[F2], located in the first and second chromosome respectively.
NLaz expression was characterized by various reporter constructs, with 3 kb of the native 5’ genomic region upstream of NLaz followed by GFP (nlaz:GFP[R2]). Alternatively, we used the same NLaz 5’ genomic region to drive the expression of GAL4 to express a membrane bound GFP (UAS:CD8-GFP line).
We used the line gmr:GAL4 to drive transgenes expression to the eye photoreceptors. The UAS:GLaz and UAS:NLaz lines have been reported [13,16]. The UAS:hATXN182Q; gmr:GAL4 line was kindly provided by Dr. J. Botas. UAS:Atg1K38Q , UAS:Atg4aC98A , UAS:Atg8a RNAiJF02895, and UAS:p62 RNAiKK105366 [47,59] were kindly provided by Dr. Gábor Juhász. All other fly lines were obtained from the Bloomington stock Center.
To combine the neurodegeneration model with GLaz over-expression and with different forms of autophagy inhibition (or other control transgenes) we constructed a fly line UAS:hATXN182Q; gmr:GAL4 UAS:GLaz2/CyO (with two transgenes in the second chromosome). After the scheme of crosses, presence of GLaz cDNA transgene was confirmed by PCR amplification from genomic DNA.
Fly heads were fixed with 4% paraformaldehyde and embedded in paraffin following standard procedures. Tissue sections (4 μm) were performed with a rotary microtome (Microm), serially mounted on Polysine™ slides (Menzel-Gläser), and dried. The sections were dewaxed in xylene and rehydrated through an ethanol series into phosphate buffered saline (PBS). Larval optic imaginal discs were dissected and fixed in 4% paraformaldehyde. The tissue was then blocked and permeabilized with TritonX-100 (0.1% in PBS) and 2% normal goat serum.
The following primary antibodies were used: Rabbit serum anti-p62 (a kind gift of Dr. Juhasz, Loránd University, Hungary; ); Rabbit serum anti-Atxn1 (a kind gift of Dr. J. Botas, Baylor College of Medicine, USA); Mouse monoclonal P4D1 anti-Ubiquitin (Cell Signaling); Rabbit serum anti-GFP (Santa Cruz Biotechnology, Inc.); Mouse monoclonal 4C5 anti-Rhodopsin (DSHB); Mouse monoclonal 22C10 anti-MAP1B (DSHB).
For HRP-IHC, the secondary antibodies HRP-conjugated Goat anti-Rabbit IgG (Abcam) and HRP-conjugated Goat anti-Mouse IgG (Dako) were used. HRP development was achieved with DAB (0.03%) and H2O2 (0.002% in 50 mM Tris, pH 8.0). Hematoxilin/Eosin and HRP-IHC sections were mounted after dehydration and clearing in Eukitt™.
For fluorescence IHC, the following secondary antibodies were used: FITC-conjugated Goat anti-Mouse and Cy3.5-conjugated Goat anti-Rabbit (Abcam). After washes in PBS, the sections were mounted with Vectashield-DAPI (Vector Labs).
The TUNEL FITC labeling kit (Roche) was used to assay apoptotic cell death in fly head tissue sections according to the manufacturer’s protocol.
Labeled sections were visualized and photographed with an Eclipse 90i (Nikon) fluorescence microscope equipped with DS-Ri1 (Nikon) digital camera. Images were acquired and processed with the NIS-Elements BR 3.0 software (Nikon).
Eye external morphology
Flies were anesthetized with CO2 and immobilized with adhesive tape. Fly eyes were photographed with a Nikon DS-L1 digital camera, in a Nikon SMZ1000 stereomicroscope equipped with a Plan Apo 1× WD70 objective. Images were processed with Adobe Photoshop 6.0 using a surface filter. Local intensity maxima were obtained with ImageJ software, and nearest neighbor distances were calculated for each ommatidia. A regularity index was estimated as the variance of distances, and a percent recovery was calculated considering 0% the average degenerated eye and 100% the control wild type eye. Samples of 20–35 flies (3d old) per condition and genotype were used to calculate the average ± S.E.M. regularity index. We have developed an optimized version of this methodology, with a freely available ImageJ plugin for automated analysis of fly eye pictures .
For scanning electron microscopy images, the flies were immobilized and pictures were taken with an ESEM-FEI-Quanta 200FEG scanning electron microscope.
RT-qPCR primer sequences
Transcription levels of mRNA were calculated with the ΔΔCT method . Statistically significant differences of gene transcriptional changes were evaluated with a Mann–Whitney U-test , using ΔCT of each replica (calculated by subtracting the average CT of the reference gene). The statistical level of significance was set at P < 0.05.
Proteins from fly heads (30–50 per condition and genotype) were solubilized by homogenization in lysis buffer, and total protein concentration was evaluated by BCA analysis (Pierce).
Immunoblot analyses were performed with 10–20 μg of total protein/lane transferred to PVDF membranes using standard procedures and exposed to the following antibodies: Rabbit serum anti-p62 (Dr. Juhasz, Loránd University, Hungary; ); Mouse monoclonal P4D1 anti-Ubiquitin (Cell Signaling). HRP-conjugated Goat anti-Rabbit or mouse IgG (DAKO) were used as secondary antibodies. HRP-conjugated anti-β actin antibody (Sigma, St Louis, MO, USA) was used to normalize protein loads. Membranes were developed with ECL (Millipore, Billerica, MA, USA), and the signal visualized with a digital camera (VersaDoc, BioRad). The integrated optical density of the immunoreactive protein bands was measured in images taken within the linear range of the camera to avoid signal saturation.
Statistical tests were performed with SigmaPlot (v 11.0) software. A P-value < 0.05 was defined as a threshold for significant changes. Means and dispersion values were calculated from experimental triplicates. The particular tests used are stated in figure legends.
Days after pupa formation
Autophagy-specific gene 8a/ Microtubule-associated protein 1A/1B-light chain 3
Central nervous system
Saccharomyces cerevisiae transcriptional regulatory protein
Green Fluorescent Protein
Glass multimer reporter promoter
Glutathione S transferase S1
- hATXN182Q :
Human Ataxin 1 with 82 glutamine tract
mammalian hematopoietic prostaglandin D synthase
Beta-D-galactosidase from Escherichia coli
PTEN induced putative kinase 1
Peripheral nervous system
Reactive oxygen species
Type 1 Spinocerebellar Ataxia
Target of rapamycin
Terminal deoxynucleotidyl transferase dUTP nick-end labeling
Upstream activating sequences
This work was supported by grants to MDG and DS: Junta de Castilla y León (JCyL) grant VA180A11-2, and Ministerio de Ciencia e Innovación (MICINN) grants BFU2008-01170 and BFU2011-23978. MdC-E was supported by a University of Valladolid, predoctoral fellowship.
We thank E. Martin-Tejedor for technical assistance, and all the Medicine and Biology students that participated in the project as part of their undergraduate education (M. Ruiz-García, R. Rojo-Engelmo, R. Sekine, S. González, A. Miller, C. Aguilera-Pino, Y. Quevedo-Aballe, S. García-García, D. Pérez-Torres, J. García-Martínez, A. de San Luis, and S. Sanz-Muñoz). We also thank the Lazarillo Lab (R. Bajo-Grañeras, M. Ruiz, N. García-Mateo, A. Pérez-Castellanos, R. Pascua-Maestro, and S. Diez-Hermano) for their helpful discussions and positive criticisms. We are grateful to Dr. J. Botas for sharing the SCA1-model Drosophila lines and the antibody against hAtaxin-1, and Dr. Gábor Juhász for sharing Drosophila lines to modify autophagy activity and the antibody against Drosophila p62. We thank M. Avella at the Electron Microscopy facility of the University of Valladolid for technical assistance with scanning EM pictures.
- Ben-Gedalya T, Cohen E. Quality control compartments coming of age. Traffic. 2012;13:635–42.View ArticlePubMedGoogle Scholar
- Jimenez-Sanchez M, Thomson F, Zavodszky E, Rubinsztein DC. Autophagy and polyglutamine diseases. Prog Neurobiol. 2012;97:67–82.View ArticlePubMed CentralPubMedGoogle Scholar
- Heng MY, Duong DK, Albin RL, Tallaksen-Greene SJ, Hunter JM, Lesort MJ, et al. Early autophagic response in a novel knock-in model of Huntington disease. Hum Mol Genet. 2010;19:3702–20.View ArticlePubMed CentralPubMedGoogle Scholar
- Nisoli I, Chauvin JP, Napoletano F, Calamita P, Zanin V, Fanto M, et al. Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy. Cell Death Differ. 2010;17:1577–87.View ArticlePubMedGoogle Scholar
- Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8:445–544.View ArticlePubMed CentralPubMedGoogle Scholar
- Cherra 3rd SJ, Chu CT. Autophagy in neuroprotection and neurodegeneration: a question of balance. Future Neurol. 2008;3:309–23.PubMed CentralPubMedGoogle Scholar
- Loos B, Engelbrecht AM. Cell death: a dynamic response concept. Autophagy. 2009;5:590–603.View ArticlePubMedGoogle Scholar
- Akerström B, Borregaard N, Flover D, Salier J, editors. Lipocalins. Georgetown, Texas: Landes Bioscience; 2006.Google Scholar
- Ruiz M, Sanchez D, Correnti C, Strong RK, Ganfornina MD. Lipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation. FEBS J. 2013;280:3928–43.View ArticlePubMedGoogle Scholar
- Morais Cabral JH, Atkins GL, Sanchez LM, Lopez-Boado YS, Lopez-Otin C, Sawyer L. Arachidonic acid binds to apolipoprotein D: implications for the protein’s function. FEBS Lett. 1995;366:53–6.View ArticlePubMedGoogle Scholar
- Vogt M, Skerra A. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J Mol Recognit. 2001;14:79–86.View ArticlePubMedGoogle Scholar
- Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ, et al. Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr Biol. 2006;16:680–6.View ArticlePubMedGoogle Scholar
- Hull-Thompson J, Muffat J, Sanchez D, Walker DW, Benzer S, Ganfornina MD, et al. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet. 2009;5:e1000460.View ArticlePubMed CentralPubMedGoogle Scholar
- Ruiz M, Sanchez D, Canal I, Acebes A, Ganfornina MD. Sex-dependent modulation of longevity by two Drosophila homologues of human Apolipoprotein D, GLaz and NLaz. Exp Gerontol. 2011;46:579–89.View ArticlePubMedGoogle Scholar
- Ruiz M, Wicker-Thomas C, Sanchez D, Ganfornina MD. Grasshopper Lazarillo, a GPI-anchored Lipocalin, increases Drosophila longevity and stress resistance, and functionally replaces its secreted homolog NLaz. Insect Biochem Mol Biol. 2012;42:776–89.View ArticlePubMedGoogle Scholar
- Walker DW, Muffat J, Rundel C, Benzer S. Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr Biol. 2006;16:674–9.View ArticlePubMedGoogle Scholar
- Muffat J, Walker DW, Benzer S. Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc Natl Acad Sci U S A. 2008;105:7088–93.View ArticlePubMed CentralPubMedGoogle Scholar
- Bajo-Graneras R, Ganfornina MD, Martin-Tejedor E, Sanchez D. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Glia. 2011;59:1551–66.View ArticlePubMedGoogle Scholar
- Bajo-Graneras R, Sanchez D, Gutierrez G, Gonzalez C, Do Carmo S, Rassart E, et al. Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J Neurochem. 2011;117:949–60.View ArticlePubMedGoogle Scholar
- Ganfornina MD, Do Carmo S, Martinez E, Tolivia J, Navarro A, Rassart E, et al. ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia. 2010;58:1320–34.PubMedGoogle Scholar
- Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell. 2008;7:506–15.View ArticlePubMed CentralPubMedGoogle Scholar
- García-Mateo N, Ganfornina MD, Montero O, Gijón MA, Murphy RC, Sanchez D. Schwann cell-derived Apolipoprotein D controls the dynamics of post-injury myelin recognition and degradation. Front Cell Neurosci. 2014;8:19.Google Scholar
- de Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009;25:875–81.View ArticlePubMed CentralPubMedGoogle Scholar
- Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, et al. Evolution of the aging brain transcriptome and synaptic regulation. PLoS One. 2008;3:e3329.View ArticlePubMed CentralPubMedGoogle Scholar
- Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, et al. Apolipoprotein D. Biochim Biophys Acta. 2000;1482:185–98.View ArticlePubMedGoogle Scholar
- Muffat J, Walker DW. Apolipoprotein D: an overview of its role in aging and age-related diseases. Cell Cycle. 2010;9:269–73.View ArticlePubMed CentralPubMedGoogle Scholar
- Dassati S, Waldner A, Schweigreiter R. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging. 2014;35:1632–42.View ArticlePubMed CentralPubMedGoogle Scholar
- Gladyshev VN. On the cause of aging and control of lifespan: heterogeneity leads to inevitable damage accumulation, causing aging; control of damage composition and rate of accumulation define lifespan. Bioessays. 2012;34:925–9.View ArticlePubMed CentralPubMedGoogle Scholar
- Navarro JA, Ohmann E, Sanchez D, Botella JA, Liebisch G, Molto MD, et al. Altered lipid metabolism in a Drosophila model of Friedreich’s ataxia. Hum Mol Genet. 2010;19:2828–40.View ArticlePubMedGoogle Scholar
- Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000;408:101–6.View ArticlePubMedGoogle Scholar
- Diez-Hermano S, Valero J, Rueda C, Ganfornina MD, Sanchez D. An automated image analysis method to measure regularity in biological patterns: a case study in a Drosophila neurodegenerative model. Mol Neurodegeneration. 2015;10:9, DOI:10.1186/s13024-015-0005-z.
- Sanchez D, Ganfornina MD, Torres-Schumann S, Speese SD, Lora JM, Bastiani MJ. Characterization of two novel lipocalins expressed in the Drosophila embryonic nervous system. Int J Dev Biol. 2000;44:349–59.PubMedGoogle Scholar
- Branco J, Al-Ramahi I, Ukani L, Perez AM, Fernandez-Funez P, Rincon-Limas D, et al. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet. 2008;17:376–90.View ArticlePubMedGoogle Scholar
- Milton VJ, Sweeney ST. Oxidative stress in synapse development and function. Dev Neurobiol. 2012;72:100–10.View ArticlePubMedGoogle Scholar
- Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885–9.View ArticlePubMedGoogle Scholar
- Juhasz G, Erdi B, Sass M, Neufeld TP. Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev. 2007;21:3061–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880–4.View ArticlePubMedGoogle Scholar
- Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy. 2008;4:176–84.View ArticlePubMedGoogle Scholar
- Erdi B, Nagy P, Zvara A, Varga A, Pircs K, Menesi D, et al. Loss of the starvation-induced gene Rack1 leads to glycogen deficiency and impaired autophagic responses in Drosophila. Autophagy. 2012;8:1124–35.View ArticlePubMed CentralPubMedGoogle Scholar
- Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci. 2013;16:1537–43.View ArticlePubMedGoogle Scholar
- Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett. 2010;584:1374–8.View ArticlePubMedGoogle Scholar
- Nezis IP, Simonsen A, Sagona AP, Finley K, Gaumer S, Contamine D, et al. Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain. J Cell Biol. 2008;180:1065–71.View ArticlePubMed CentralPubMedGoogle Scholar
- Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–45.View ArticlePubMedGoogle Scholar
- Bartlett BJ, Isakson P, Lewerenz J, Sanchez H, Kotzebue RW, Cumming RC, et al. p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy. 2011;7:572–83.View ArticlePubMed CentralPubMedGoogle Scholar
- Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181–97.View ArticlePubMedGoogle Scholar
- Scott RC, Juhasz G, Neufeld TP. Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Curr Biol. 2007;17:1–11.View ArticlePubMed CentralPubMedGoogle Scholar
- Pircs K, Nagy P, Varga A, Venkei Z, Erdi B, Hegedus K, et al. Advantages and limitations of different p62-based assays for estimating autophagic activity in Drosophila. PLoS One. 2012;7:e44214.View ArticlePubMed CentralPubMedGoogle Scholar
- Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, et al. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J Neurochem. 2004;91:57–68.View ArticlePubMedGoogle Scholar
- Meske V, Erz J, Priesnitz T, Ohm TG. The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability. Neurobiol Dis. 2014;64:88–97.View ArticlePubMedGoogle Scholar
- Heraud C, Griffiths A, Pandruvada SN, Kilimann MW, Pata M, Vacher J. Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency. J Biol Chem. 2014;289:13912–25.View ArticlePubMedGoogle Scholar
- Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007;26:1749–60.View ArticlePubMed CentralPubMedGoogle Scholar
- Scherz-Shouval R, Shvets E, Elazar Z. Oxidation as a post-translational modification that regulates autophagy. Autophagy. 2007;3:371–3.View ArticlePubMedGoogle Scholar
- Ishii T, Yanagawa T, Yuki K, Kawane T, Yoshida H, Bannai S. Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages. Biochem Biophys Res Commun. 1997;232:33–7.View ArticlePubMedGoogle Scholar
- Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 2010;285:22576–91.View ArticlePubMed CentralPubMedGoogle Scholar
- Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183:795–803.View ArticlePubMed CentralPubMedGoogle Scholar
- Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8:e1000298.View ArticlePubMed CentralPubMedGoogle Scholar
- Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, Terman A. Autophagy and aging: the importance of maintaining “clean” cells. Autophagy. 2005;1:131–40.View ArticlePubMedGoogle Scholar
- Jin D, Zhang Y, Chen X. Lipocalin 2 deficiency inhibits cell proliferation, autophagy, and mitochondrial biogenesis in mouse embryonic cells. Mol Cell Biochem. 2011;351:165–72.View ArticlePubMedGoogle Scholar
- Nagy P, Varga A, Pircs K, Hegedus K, Juhasz G. Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogaster. PLoS Genet. 2013;9:e1003664.View ArticlePubMed CentralPubMedGoogle Scholar
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–8.View ArticlePubMedGoogle Scholar
- Yuan JS, Reed A, Chen F, Stewart Jr CN. Statistical analysis of real-time PCR data. BMC Bioinformatics. 2006;7:85.View ArticlePubMed CentralPubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.